Healthcare -
Biotechnology - NASDAQ - US
$ 3.35
0.601 %
$ 2.33 M
Market Cap
0.0
P/E
RNAZ - RESEARCH & DEVELOPMENT
Research & Development RNAZ - TransCode Therapeutics, Inc.
12.3 M
LAST VALUE
111.02%
2 YEAR CAGR
171.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR